Toll-like receptor 3 (TLR3), a crucial member of TLRs (Bianchi et al., 2017), whose absence can lead to autoimmune diseases, septicemia, chronic inflammation and cancer, among other pathological conditions (Le Naour et al., 2020). This evidence concerns the gene TLR3 and cancer.